5C Network, a Bengaluru-based online medical diagnostics platform with a strategic investment from Tata 1MG, acquired US-based artificial intelligence healthtech firm Krayen. 5C Network expects this acquisition to triple its digital scans to a billion per year by 2025.
In October 2022, deep tech venture capital firm Celesta Capital led 5C Network’s $4.6 million Series A fundraising. Unitus Ventures, Axilor Ventures, and angel investors Ajay Gupta, Rohit Razdan, and Shiv Tallam joined the round.
The $11 billion Indian medical diagnostics business is growing 16% annually. 5C aims to change the entire diagnostic experience for patients, from booking a test to receiving accurate and fast reports digitally, with an average turnaround time of 39 minutes and an accuracy of over 99.3%.
Californians Bargava Subramanian and Kirthiraj Yuvaraj established Krayen in 2020. Computer vision and natural language processing help hospitals improve patient outcomes with Krayen. 15 international Krayen clients.
The startup’s vertically-focused generative AI allows hospitals to deliver customised treatment plans. By analysing medical history, genetics, and lifestyle factors, the platform recommends personalised treatments.
We want to use Krayen’s platform engineering, data, and AI/ML expertise. 5C Network CEO Kalyan Sivasailam said, “We’re building an intelligent, powerful platform to accommodate a billion scans every year. Krayen’s ability to handle massive amounts of data and deliver insightful information will help 5C achieve this. Bargava Subramanian, Krayen’s cofounder and CEO, says 5C Network is building India’s most important digital resources.
Our expertise in AI, ML, deep learning, and data engineering is essential to improving diagnostics.”
We have experienced delayed, incorrect, and inactionable diagnosis as a team. He said that since Krayen shares 5C’s vision and objective, we’re more motivated than ever to reach this goal.